Infertility News and Research

RSS
Infertility primarily refers to the biological inability of a person to contribute to conception. Infertility may also refer to the state of a woman who is unable to carry a pregnancy to full term.
BioLineRx enrolls first patient in BL-7010 Phase 1/2 trial for treatment of celiac disease

BioLineRx enrolls first patient in BL-7010 Phase 1/2 trial for treatment of celiac disease

Cedars-Sinai physicians awarded grant to study pregnancy problems resulting from fertility treatments

Cedars-Sinai physicians awarded grant to study pregnancy problems resulting from fertility treatments

Endocrine Society issues scientific statement on health consequences of performance-enhancing drugs

Endocrine Society issues scientific statement on health consequences of performance-enhancing drugs

Queen's University professor wins Gold Award for Innovation for research on male infertility

Queen's University professor wins Gold Award for Innovation for research on male infertility

New assay allows rapid and sensitive detection of Chlamydia trachomatis

New assay allows rapid and sensitive detection of Chlamydia trachomatis

Researchers assess direct out-of-pocket costs for couples undergoing fertility treatment

Researchers assess direct out-of-pocket costs for couples undergoing fertility treatment

New male contraceptive pill could soon be available

New male contraceptive pill could soon be available

EMD Serono's TocopheRx to focus on development of oral FSH agonists for infertility treatment

EMD Serono's TocopheRx to focus on development of oral FSH agonists for infertility treatment

Women & Infants gets $3M grant to identify infants at greatest risk for developmental impairment

Women & Infants gets $3M grant to identify infants at greatest risk for developmental impairment

Oxford scientists use nanoparticles to study mechanisms underlying 'mystery' cases of infertility

Oxford scientists use nanoparticles to study mechanisms underlying 'mystery' cases of infertility

OvaScience reports net loss of $6.9 million in Q3 2013

OvaScience reports net loss of $6.9 million in Q3 2013

Tailored doses of pre-transplant drug therapy in Glaucomatous patients boosts survival rates to over 90%

Tailored doses of pre-transplant drug therapy in Glaucomatous patients boosts survival rates to over 90%

Merck Serono signs co-development and commercialization agreement for BeiGene-290

Merck Serono signs co-development and commercialization agreement for BeiGene-290

Two organochlorine pesticides associated with increased risk of endometriosis

Two organochlorine pesticides associated with increased risk of endometriosis

Endocrine Society issues Clinical Practice Guideline for polycystic ovary syndrome

Endocrine Society issues Clinical Practice Guideline for polycystic ovary syndrome

Researchers improve cytostatic therapy for children with chronic immune deficiency disorder

Researchers improve cytostatic therapy for children with chronic immune deficiency disorder

First Edition: October 22, 2013

First Edition: October 22, 2013

RMA of New York partners with Mount Sinai Medical Center to study long-term effects of PCOS

RMA of New York partners with Mount Sinai Medical Center to study long-term effects of PCOS

Study finds increase in use of donor eggs for in vitro fertilization

Study finds increase in use of donor eggs for in vitro fertilization

Nutrition tips for women looking to conceive

Nutrition tips for women looking to conceive

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.